Nothing is too precious for designer Jamison Lung, who takes us through how she rebels against type conventions.

Speakers at the 2024 World Conference on Lung Cancer discussed the considerations that must go into designing and performing clinical trials in the early-stage lung cancer space, ranging from ...

PRESERVE-003 is evaluating gotistobart vs. docetaxel in patients with squamous non-small cell lung cancer (sqNSCLC) who have ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced a poster ...

Merck has shared positive results from the Phase II IDeate-Lung01 trial (NCT05280470) evaluating ifinatamab deruxtecan (I-DXd) in patients with previously treated extensive-stage small cell lung ...

Engineers from MIT and the University of Massachusetts Medical School have created a new type of nanoparticle that can perform gene editing in the lungs, as per a press release. This could lead to ...

Lung cancer researchers are emphasizing the importance of combating the misconception that only smokers are at risk for lung ...

Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to a new study in Cancer Cell led by researchers at ...

Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

PRESERVE-003 is evaluating gotistobart vs. docetaxel in patients with squamous non-small cell lung cancer (sqNSCLC) who have ...